The scaffold protein KSR1, a novel therapeutic target for the treatment of Merlin-deficient tumors

L. Zhou; J. Lyons-Rimmer; S. Ammoun; J. Müller; E. Lasonder; V. Sharma; E. Ercolano; D. Hilton; I. Taiwo; M. Barczyk; C. O. Hanemann

doi:10.1038/onc.2015.404

The scaffold protein KSR1, a novel therapeutic target for the treatment of Merlin-deficient tumors

L. Zhou^*, J. Lyons-Rimmer, S. Ammoun, J. Müller, E. Lasonder, V. Sharma, E. Ercolano, D. Hilton, I. Taiwo, M. Barczyk, C. O. Hanemann

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

11 Downloads (Pure)

Original language	English
Pages (from-to)	3443-3453
Number of pages	0
Journal	Oncogene
Volume	35
Issue number	26
DOIs	https://doi.org/10.1038/onc.2015.404
Publication status	Published - 30 Jun 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/onc.2015.404

Zhou et al Oncongene 2016

Cite this

@article{83dc8f416a884422a6cd1cb8c4bca830,

title = "The scaffold protein KSR1, a novel therapeutic target for the treatment of Merlin-deficient tumors",

author = "L. Zhou and J. Lyons-Rimmer and S. Ammoun and J. M{\"u}ller and E. Lasonder and V. Sharma and E. Ercolano and D. Hilton and I. Taiwo and M. Barczyk and Hanemann, {C. O.}",

year = "2016",

month = jun,

day = "30",

doi = "10.1038/onc.2015.404",

language = "English",

volume = "35",

pages = "3443--3453",

journal = "Oncogene",

issn = "0950-9232",

publisher = "Nature Publishing Group",

number = "26",

}

TY - JOUR

T1 - The scaffold protein KSR1, a novel therapeutic target for the treatment of Merlin-deficient tumors

AU - Zhou, L.

AU - Lyons-Rimmer, J.

AU - Ammoun, S.

AU - Müller, J.

AU - Lasonder, E.

AU - Sharma, V.

AU - Ercolano, E.

AU - Hilton, D.

AU - Taiwo, I.

AU - Barczyk, M.

AU - Hanemann, C. O.

PY - 2016/6/30

Y1 - 2016/6/30

U2 - 10.1038/onc.2015.404

DO - 10.1038/onc.2015.404

M3 - Article

SN - 0950-9232

VL - 35

SP - 3443

EP - 3453

JO - Oncogene

JF - Oncogene

IS - 26

ER -